Molecular Mechanisms Mediating Ceftazidime/Avibactam Resistance Amongst Carbapenem-Resistant Klebsiella pneumoniae Isolates from Cancer Patients

BACKGROUND: A growing body of evidence suggests that ceftazidime/avibactam (CZA) is a potential therapeutic option for carbapenem-resistant Klebsiella pneumoniae (CRKP) infections; however, resistant strains are increasingly emerged worldwide. Herein, we deemed to investigate the susceptibility prof...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Kady, Rania Abd El-Hamid, Elbaiomy, Mohamed Ali, Elnagar, Rasha Mokhtar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558567/
https://www.ncbi.nlm.nih.gov/pubmed/36247738
http://dx.doi.org/10.2147/IDR.S384972

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558567/
https://www.ncbi.nlm.nih.gov/pubmed/36247738
http://dx.doi.org/10.2147/IDR.S384972

Ejemplares similares